You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

FLUCINOLONE ACETONIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Flucinolone Acetonide, and what generic alternatives are available?

Flucinolone Acetonide is a drug marketed by Glenmark Pharms Ltd and is included in one NDA.

The generic ingredient in FLUCINOLONE ACETONIDE is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Flucinolone Acetonide

A generic version of FLUCINOLONE ACETONIDE was approved as fluocinolone acetonide by TARO on April 27th, 1982.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FLUCINOLONE ACETONIDE?
  • What are the global sales for FLUCINOLONE ACETONIDE?
  • What is Average Wholesale Price for FLUCINOLONE ACETONIDE?
Drug patent expirations by year for FLUCINOLONE ACETONIDE
Recent Clinical Trials for FLUCINOLONE ACETONIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Samsung Medical CenterPhase 4
Asan Medical CenterPhase 4
Kyunghee University Medical CenterPhase 4

See all FLUCINOLONE ACETONIDE clinical trials

Pharmacology for FLUCINOLONE ACETONIDE

US Patents and Regulatory Information for FLUCINOLONE ACETONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Ltd FLUCINOLONE ACETONIDE fluocinolone acetonide OIL;TOPICAL 210556-001 Oct 25, 2018 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.